Patient no. | Sex | Age (y) | Age at onset (y) | Duration of epilepsy (y) | Seizure frequency | Seizure laterality | Treatment |
---|---|---|---|---|---|---|---|
1 | F | 56 | 3 | 53 | 4–15 per month | L | CBZ + TPM + PB |
2 | M | 23 | 15 | 8 | 1 per day | L | OXC + LTG + CLN |
3 | F | 38 | 1.5 | 36 | 5 per month | L | CBZ + LEV + TPM |
4 | M | 39 | 16 | 23 | 5–12 per month | R | CBZ + LTG |
5 | F | 42 | 20 | 22 | 2 per week | R | OXC |
6 | M | 33 | 6 | 27 | 5 per month | L | OXC + LTG |
7 | M | 28 | 10 | 18 | 5–10 per month | L | OXC + LEV + CLB |
8 | F | 35 | 2.5 | 32 | 5 per month | L | CBZ + GBP |
9 | M | 22 | 8 | 14 | 3 per month | R | CBZ + GBP |
CBZ = carbamazepine; TPM = topiramate; PB = phenobarbital; OXC = oxcarbamazepine; LTG = lamotrigine; CLN = clonazepam; LEV = levetiracetam; CLB = clobazam; GBP = gabapentin.